CASTELLI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 694
AS - Asia 581
EU - Europa 373
SA - Sud America 184
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.850
Nazione #
US - Stati Uniti d'America 659
SG - Singapore 202
CN - Cina 198
BR - Brasile 152
SE - Svezia 115
IT - Italia 85
HK - Hong Kong 76
VN - Vietnam 57
DE - Germania 52
RU - Federazione Russa 28
FI - Finlandia 25
CA - Canada 23
GB - Regno Unito 17
PL - Polonia 17
AR - Argentina 12
FR - Francia 12
MX - Messico 11
IN - India 10
ZA - Sudafrica 9
EC - Ecuador 8
JP - Giappone 8
NL - Olanda 5
TR - Turchia 5
BD - Bangladesh 4
CO - Colombia 4
ES - Italia 4
IE - Irlanda 4
UZ - Uzbekistan 4
CL - Cile 3
ID - Indonesia 3
IQ - Iraq 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
EG - Egitto 2
JO - Giordania 2
PK - Pakistan 2
PY - Paraguay 2
RO - Romania 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MU - Mauritius 1
PE - Perù 1
PH - Filippine 1
SN - Senegal 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 1.850
Città #
Dallas 235
Ashburn 108
Singapore 99
Hong Kong 76
Milan 53
Shanghai 50
Beijing 42
Hefei 30
Ho Chi Minh City 27
Los Angeles 25
New York 24
Princeton 24
Lawrence 23
Helsinki 18
Munich 17
São Paulo 17
Warsaw 15
Moscow 13
Hanoi 11
Brescia 9
Falkenstein 9
Stockholm 8
Tokyo 8
Atlanta 7
Orem 7
Cesano Boscone 6
Chennai 6
London 6
Montreal 6
Nuremberg 6
Amsterdam 5
Boston 5
Brooklyn 5
Denver 5
Frankfurt am Main 5
Johannesburg 5
Poplar 5
Rome 5
Toronto 5
Chicago 4
Columbus 4
Dublin 4
Guangzhou 4
The Dalles 4
Vancouver 4
Bologna 3
Frankfurt Am Main 3
Guayaquil 3
Joinville 3
Lappeenranta 3
Manaus 3
Mexico City 3
Phoenix 3
Salvador 3
San Francisco 3
Santa Clara 3
Seattle 3
Tashkent 3
Turku 3
Xi'an 3
Amman 2
Ancona 2
Ankara 2
Bandung 2
Barra Mansa 2
Betim 2
Boardman 2
Bogotá 2
Brasília 2
Calgary 2
Cape Town 2
Como 2
Curitiba 2
Da Nang 2
Erbil 2
Ferraz de Vasconcelos 2
Florianópolis 2
Haiphong 2
Houston 2
Jiaxing 2
Kassel 2
Muriaé 2
New Delhi 2
Ninh Bình 2
Niterói 2
Passo Fundo 2
Pune 2
Quito 2
Santo André 2
São José 2
São José dos Campos 2
Washington 2
Wroclaw 2
Abu Dhabi 1
Americana 1
Anita Garibaldi 1
Aparecida de Goiânia 1
Apatzingán 1
Aracaju 1
Arapiraca 1
Totale 1.172
Nome #
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 148
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 96
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 91
A Biologically-validated HCV E1E2 Heterodimer Structural Model 86
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 86
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 82
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 79
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 76
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 75
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 71
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 66
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 65
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 64
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 63
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 61
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 61
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 58
Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets 57
Role and potential therapeutic use of antibodies against herpetic infections 53
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 51
HCV E2 core structures and mAbs: something is still missing 49
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 48
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 48
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 46
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 46
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 44
Viral Respiratory Pathogens and Lung Injury 42
Salts drive controllable multilayered upright assembly of amyloid-like peptides at mica/water interface 41
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening 38
Erratum: Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets (Nature Nanotechnology (2013) 8 (594-601)) 27
null 1
Totale 1.919
Categoria #
all - tutte 11.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.895


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 1 0 0 5 0 0
2021/202230 2 1 7 4 0 0 0 2 2 3 3 6
2022/2023186 57 45 25 1 1 27 10 11 7 0 2 0
2023/2024161 0 9 26 30 14 33 4 20 4 9 1 11
2024/2025451 45 11 6 19 20 51 82 79 49 28 32 29
2025/20261.043 153 171 271 254 164 30 0 0 0 0 0 0
Totale 1.919